COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring.
| Revenue (Most Recent Fiscal Year) | $6.22M |
| Net Income (Most Recent Fiscal Year) | $0.03M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 25.42 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.57 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.18 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 4.43 |
| Pre-Tax Margin (Trailing 12 Months) | 0.17% |
| Net Margin (Trailing 12 Months) | 2.27% |
| Return on Equity (Trailing 12 Months) | 4.83% |
| Return on Assets (Trailing 12 Months) | 3.33% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.28 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.26 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.16 |
| Inventory Turnover (Trailing 12 Months) | 7.03 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.49 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.12 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 1.33M |
| Free Float | 1.03M |
| Market Capitalization | $4.04M |
| Average Volume (Last 20 Days) | 1256.15 |
| Beta (Past 60 Months) | -0.30 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 22.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |